About 600 Sero-discordant couples where one partner is HIV positive and the
other is not will take part in a new research study to help decide the best
HIV Treatment Strategy that will reduce the rate of infection in the
population.
A study by the National Agency for Control of AIDS (NACA) is to help decide
whether health workers choose to administer the anti-retroviral drug,
Truvada- as a prevention or treatment for HIV/AIDS.
Multiple studies have established that anti-retroviral drugs could be used to
reduce the rate of infection in a population in two different ways, known by
the acronyms PrEP (Pre-Exposure Prophylaxis) and TasP (Treatment as
Prevention).
Director General, National Agency for Control of AIDS (NACA), Prof. John
Idoko disclosed that the study is being carried out in Nigeria to see if it will
work under normal conditions.
"The whole idea is to see if it will work so well in this situation, and if it
does, it will become a policy. NACA understands that, given the data and
experience to be gained from the project, it should be possible to present
this to stakeholders for consideration as part of policy and guidelines for the
comprehensive combination preventing program in the country."
Keep staying Healthy, Informed and Entertained...
No comments:
Post a Comment
Keep staying Healthy, Informed and Entertained...
Your comments/views will be appreciated.... Thanks